Navigation Links
Got inexpensive contrast agent? Milk plays new role in imaging

In a new twist on the slogan “milk does a body good,?radiologists are testing use of the dairy staple as a contrast agent in gastrointestinal imaging exams—with excellent results. The researchers reported their findings today at the annual meeting of the Radiological Society of North America (RSNA).

“We are able to achieve similar bowel distension and enhancement as we see with the commonly used contrast agent, VoLumen,?said Lisa R. Shah-Patel, M.D., a radiology resident at St. Luke’s-Roosevelt Hospital in New York City. “In addition, we found that patients are more willing to drink milk because it is part of their daily lives, and they know what to expect.?

Computed tomography (CT) imaging of the gastrointestinal tract is often done for abdominal pain. When the condition calls for visualization of the small intestinal wall, a negative oral contrast agent should be used. VoLumen is a barium-based oral contrast agent that works with intravenous contrast to allow better visualization of the bowel wall and clearer delineation between the bowel cavity and soft tissue.

When milk is used, the milk-filled intestinal cavity appears dark, while the intestinal wall appears bright due to intravenous contrast enhancement. The dark intestinal cavity contrasting with the bright intestinal wall makes any evidence of disease on the bowel wall more visible.

The researchers studied 179 adult patients undergoing CT with oral and intravenous contrast for abdominal discomfort to compare cost effectiveness and patient tolerance for whole milk versus VoLumen. Sixty-two patients received VoLumen, and 117 received milk. Of the 57 VoLumen patients who completed a subsequent questionnaire, 24 (42 percent) experienced abdominal discomfort such as cramps, diarrhea and nausea, while only 27 (23 percent) of the 117 patients who received milk reported abdominal discomfort.

Overall, milk was found to be just as effective as VoLumen in bowel distensio n (expansion) and bowel-wall conspicuity (enhancement). One important difference is the price. VoLumen costs $18 per patient, while whole milk costs $1.39 per patient.

“There are several advantages to milk. Patients are more willing to drink milk than VoLumen, and it costs a fraction of the price,?Dr. Shah-Patel said. “We hope that substituting milk for other contrast agents will reduce the number of people who refuse imaging tests because they do not want to drink the oral contrast, especially children.?
'"/>

Source:Radiological Society of North America


Related biology news :

1. Gadonanotubes greatly outperform existing MRI contrast agents
2. Gallium: A new antibacterial agent?
3. White blood cell waste disposal system plays critical regulatory role
4. Micro-molecule plays big role in birth defects
5. Sleeping beauty plays a significant role in identifying cancer genes
6. Neural stem cell gene plays crucial role in eye development
7. Zinc plays important role in brain circuitry
8. Fish species plays surprise role in aiding coral reef recovery
9. Anticipation plays a powerful role in human memory, brain study finds
10. Motor protein plays key role in connecting neurons
11. Confirmed -- deforestation plays critical climate change role

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/13/2017)... -- Former 9/11 Commission border counsel and Special Counsel ... of Identity Strategy Partners, LLP, today releases the ... Order: Protecting the Nation From Foreign Terrorist Entry Into ... President Trump,s ,Travel Ban, Executive Order gains more notoriety ... travel ban, it is important that our national discourse ...
(Date:2/8/2017)... (NASDAQ: AWRE ), a leading supplier of biometrics ... and year ended December 31, 2016. Revenue ... to $6.9 million in the same quarter last year. Operating ... compared to $2.6 million in the fourth quarter of 2015. ... million, or $0.02 per diluted share, which compares to $1.8 ...
(Date:2/7/2017)...   MedNet Solutions , an innovative SaaS-based eClinical ... research, is pleased to announce that the latest release ... flexible and award winning eClinical solution, is now available ... is a proven Software-as-a-Service (SaaS) clinical research technology platform ... also delivers an entire suite of eClinical tools to ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... Staten Island, NY (PRWEB) , ... February 24, 2017 , ... ... exponential rate. Founded in late 2014, FireflySci had the goal of bringing their ... 2017, that goal continues to shape the path that FireflySci is going on as ...
(Date:2/24/2017)... 24, 2017  OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), ... a Key Opinion Leader event to highlight new clinical ... poster presentation at the upcoming 2017 ASCO-SITC Immuno-Oncology Symposium ... will be held in-person and via live webcast on ... AM PST at the Lotte New York Palace Hotel ...
(Date:2/23/2017)... ... February 23, 2017 , ... BellBrook ... portfolio to include an array of biochemical analyses critical for Lead Discovery. ... their hit-to-lead and SAR programs, including inhibitor potency and selectivity, mechanism of action, ...
(Date:2/23/2017)... 23, 2017  In Atlanta, it seems everyone has a ... intertwine to create an expressive and dynamic community unlike any ... and contribute to it. With their newest ... seeks to carry on that tradition with a unique, ... salon is the newest of 13 nationwide locations, ...
Breaking Biology Technology: